TScan Therapeutics Inc. logo

TScan Therapeutics Inc. (TCRX)

Market Open
11 Sep, 14:07
NASDAQ (NMS) NASDAQ (NMS)
$
0. 31
-0
-1.447%
$
21.06M Market Cap
- P/E Ratio
- Div Yield
194,524 Volume
-1.04 Eps
$ 0.32
Previous Close
Investors:
Add Transaction
Day Range
0.31 0.32
Year Range
0.31 2.57
Want to track TCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

TScan Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
John H. Burbank III
John H. Burbank III Passport Capital LLC
2.78M $16.16M $1.07M -$15.1M -93.41%
Kyle P. Smith
Kyle P. Smith NewEdge Wealth LLC
91,463 $141,767.65 $28,701.09 -$113,066.56 -79.75%
Dinan Hu
Dinan Hu R Squared Ltd
18,360 $17,995 $5,825.63 -$12,169.37 -67.63%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
1 $1 $0.31 -$0.69 -69%